Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2018-02-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于高级管理人员变更的公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from a company regarding changes in its senior management personnel. It details the appointment of a new vice general manager and the resignation of the previous one, including compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about changes in the company's board or senior management.
2018-02-09 Chinese
第三届董事会第八次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a board meeting resolution regarding the appointment of a new deputy general manager. It includes details about the meeting, voting results, and the appointee's resume. There is no financial data, earnings information, or report publication mentioned. The content focuses on management changes, specifically the appointment of a senior executive. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2018-02-09 Chinese
关于公司控股子公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acceptance of medical device registration applications by a controlling subsidiary. It details the products and their clinical uses, the regulatory approval stage, and states that this acceptance will not impact recent performance. The document is short (1903 characters) and serves as a notification of regulatory progress rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. It is an official regulatory announcement about product registration acceptance, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2018-02-05 Chinese
第三届监事会第三次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of the company, specifically regarding an employee stock ownership plan and its management rules. It includes voting results and mentions that the proposals will be submitted to the shareholders' meeting for approval. The document is short (1635 characters) and does not contain financial statements or detailed financial data. It is not a full report but an announcement of board/management decisions related to governance and employee stock plans. This fits best under Board/Management Information (MANG), as it concerns decisions made by the supervisory board and management-level governance matters.
2018-02-04 Chinese
关于召开2018年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2018 first extraordinary general meeting of shareholders for Dirui Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items for shareholder approval, registration methods, and proxy forms. The content focuses on the announcement and procedural details for the shareholders' meeting rather than the results of the meeting or the minutes. There is no indication that this document contains voting results or the actual report of the meeting. It is not a full annual or interim report, nor an earnings release or management discussion. It is clearly a notice to shareholders about the meeting and how to participate and vote. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2018-02-04 Chinese
第一期员工持股计划管理办法
Regulatory Filings Classification · 95% confidence The document is titled as the "First Employee Stock Ownership Plan Management Measures" of Dirui Medical Technology Co., Ltd. It details the principles, implementation procedures, management structure, rights and obligations, funding sources, stock sources, lock-up periods, and termination conditions of an employee stock ownership plan. It references relevant laws and regulatory guidelines related to employee stock ownership plans in China. The document is a comprehensive policy and procedural manual for the employee stock ownership plan rather than a financial report, announcement of voting results, or a regulatory filing. It does not contain financial statements, earnings data, or audit information. It is not a presentation or transcript. It is a detailed governance and management document specific to the employee stock ownership plan. Therefore, the most appropriate classification is a Regulatory Filing (RNS) as it is a compliance and governance document that does not fit other specific categories.
2018-02-04 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.